Intra-articular liposomal therapy.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000008:administration & dosage; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001169:Arthritis, Experimental / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002908:Chronic Disease; D003630:Daunorubicin / Q000008:administration & dosage; D005544:Forecasting; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007477:Ions; D008081:Liposomes / Q000008:administration & dosage*; D008722:Methods; D014677:Pharmaceutical Vehicles; D010713:Phosphatidylcholines; D012995:Solubility; D013329:Structure-Activity Relationship; D013696:Temperature
D000893:Anti-Inflammatory Agents; D007477:Ions; D008081:Liposomes; D014677:Pharmaceutical Vehicles; D010713:Phosphatidylcholines; D015117:5,8,11,14-Eicosatetraynoic Acid; D006854:Hydrocortisone; D003630:Daunorubicin